Back to: products

Global Artificial Intelligence (AI) in Drug Discovery Market 2020-2026 by Offering, Technology, Drug Type, Therapeutic Area, Application, End User, and Region: Trend Forecast

PrintEmail
May 2020 - 178 Pages - From $2,980
(Excel Data Sheet: $1,800)
Description

The report cover may be different from the image shown.

Product and Price

By clicking the Add to Shopping Cart button, you certify to agree with our Terms of Service.

Global artificial intelligence (AI) in drug discovery market will reach $2.57 billion by 2026, growing by 30.3% annually over 2020-2026 despite the COVID-19 impact.
Highlighted with 86 tables and 86 figures, this 178-page report “Global Artificial Intelligence (AI) in Drug Discovery Market 2020-2026 by Offering, Technology, Drug Type, Therapeutic Area, Application, End User, and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global AI in drug discovery market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report provides historical market data for 2015-2019, revenue estimates for 2020, and forecasts from 2021 till 2026. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global AI in drug discovery market in every aspect of the classification from perspectives of Offering, Technology, Drug Type, Therapeutic Area, Application, End User, and Region.
Based on offering, the global market is segmented into the following sub-markets with annual revenue for 2015-2026 (historical and forecast) included in each section.
• Software
• Service
Based on technology, the global market is segmented into the following sub-markets with annual revenue for 2015-2026 (historical and forecast) included in each section.
• Deep Learning
• Supervised Learning
• Reinforcement Learning
• Unsupervised Learning
• Other Technologies
Based on drug type, the global market is segmented into the following sub-markets with annual revenue for 2015-2026 (historical and forecast) included in each section.
• Large-molecule Drugs
• Small-molecular Drugs
Based on therapeutic area, the global market is segmented into the following sub-markets with annual revenue for 2015-2026 (historical and forecast) included in each section.
• Oncology
• Neurodegenerative Diseases
• Cardiovascular Disease
• Metabolic Diseases
• Other Therapeutic Areas
Based on application, the global market is segmented into the following sub-markets with annual revenue for 2015-2026 (historical and forecast) included in each section.
• Information & Data Analysis
• Drug Design
• Drug Evaluation
• Clinical Trials
• Other Applications
Based on end user, the global market is segmented into the following sub-markets with annual revenue for 2015-2026 (historical and forecast) included in each section.
• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Contract Research Organizations
Geographically, the following regions together with the listed national/local markets are fully investigated:
• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka)
• Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Belgium, Denmark, Austria, Norway, Sweden, The Netherlands, Poland, Czech Republic, Slovakia, Hungary, and Romania)
• North America (U.S., Canada, and Mexico)
• South America (Brazil, Chile, Argentina, Rest of South America)
• RoW (Saudi Arabia, UAE, Egypt)
For each of the aforementioned regions and countries, detailed analysis and data for annual revenue are available for 2015-2026. The breakdown of all regional markets by country and split of key national markets by Technology, Therapeutic Area, and End User over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Specifically, potential risks associated with investing in global AI in drug discovery market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
Key Players (this may not be a complete list and extra companies can be added upon request):
Atomwise, Inc.
BenevolentAI
Berg LLC
Bioage
BIOAGE
Cloud Pharmaceuticals, Inc.
Cyclica
Deep Genomics
Envisagenics
Exscientia
Google
IBM Corporation
Insilico Medicine
Microsoft Corporation
Numedii, Inc.
Numerate
NVIDIA Corporation
Owkin, Inc.
Twoxar, Incorporated
Verge Genomics
Xtalpi, Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

1 Introduction 10
1.1 Industry Definition and Research Scope 10
1.1.1 Industry Definition 10
1.1.2 Research Scope 11
1.2 Research Methodology 14
1.2.1 Overview of Market Research Methodology 14
1.2.2 Market Assumption 15
1.2.3 Secondary Data 15
1.2.4 Primary Data 15
1.2.5 Data Filtration and Model Design 17
1.2.6 Market Size/Share Estimation 18
1.2.7 Research Limitations 19
1.3 Executive Summary 20
2 Market Overview and Dynamics 23
2.1 Market Size and Forecast 23
2.2 Major Growth Drivers 25
2.3 Market Restraints and Challenges 28
2.4 Emerging Opportunities and Market Trends 31
2.5 Porter’s Fiver Forces Analysis 35
3 Segmentation of Global Market by Offering 39
3.1 Market Overview by Offering 39
3.2 Software 41
3.3 Service 42
4 Segmentation of Global Market by Technology 43
4.1 Market Overview by Technology 43
4.2 Deep Learning 45
4.3 Supervised Learning 46
4.4 Reinforcement Learning 47
4.5 Unsupervised Learning 48
4.6 Other Technologies 49
5 Segmentation of Global Market by Drug Type 50
5.1 Market Overview by Drug Type 50
5.2 Large-molecule Drugs 52
5.3 Small-molecular Drugs 53
6 Segmentation of Global Market by Therapeutic Area 54
6.1 Market Overview by Therapeutic Area 54
6.2 Oncology 57
6.3 Neurodegenerative Diseases 58
6.4 Cardiovascular Disease 59
6.5 Metabolic Diseases 60
6.6 Other Therapeutic Areas 61
7 Segmentation of Global Market by Application 62
7.1 Market Overview by Application 62
7.2 Information & Data Analysis 64
7.3 Drug Design 65
7.4 Drug Evaluation 66
7.5 Clinical Trials 67
7.6 Other Applications 68
8 Segmentation of Global Market by End User 69
8.1 Market Overview by End User 69
8.2 Pharmaceutical & Biotechnology Companies 71
8.3 Academic & Research Institutes 72
8.4 Contract Research Organizations 73
9 Segmentation of Global Market by Region 74
9.1 Geographic Market Overview 2019-2026 74
9.2 North America Market 2019-2026 by Country 78
9.2.1 Overview of North America Market 78
9.2.2 U.S. 82
9.2.3 Canada 86
9.2.4 Mexico 88
9.3 European Market 2019-2026 by Country 90
9.3.1 Overview of European Market 90
9.3.2 UK 94
9.3.3 France 96
9.3.4 Germany 98
9.3.5 Spain 100
9.3.6 Italy 102
9.3.7 Russia 104
9.3.8 Rest of European Market 106
9.4 Asia-Pacific Market 2019-2026 by Country 108
9.4.1 Overview of Asia-Pacific Market 108
9.4.2 China 111
9.4.3 Japan 113
9.4.4 India 116
9.4.5 Australia 118
9.4.6 South Korea 120
9.4.7 Rest of APAC Region 122
9.5 South America Market 2019-2026 by Country 124
9.5.1 Argentina 127
9.5.2 Brazil 129
9.5.3 Chile 131
9.5.4 Rest of South America Market 133
9.6 Rest of World Market 2019-2026 by Country 134
9.6.1 UAE 137
9.6.2 Saudi Arabia 139
9.6.3 Egypt 141
9.6.4 Other National Markets 143
10 Competitive Landscape 144
10.1 Overview of Key Vendors 144
10.2 New Product Launch, Partnership, Investment, and M&A 149
10.3 Company Profiles 150
Atomwise, Inc. 150
BenevolentAI 152
Berg LLC 153
Bioage 154
BIOAGE 155
Cloud Pharmaceuticals, Inc. 156
Cyclica 157
Deep Genomics 158
Envisagenics 159
Exscientia 160
Google 161
IBM Corporation 162
Insilico Medicine 163
Microsoft Corporation 164
Numedii, Inc. 165
Numerate 166
NVIDIA Corporation 167
Owkin, Inc. 168
Twoxar, Incorporated 169
Verge Genomics 170
Xtalpi, Inc. 171
11 Investing in Global Market: Risk Assessment and Management 172
11.1 Risk Evaluation of Global Market 172
11.2 Critical Success Factors (CSFs) 175
Related Reports and Products 178

List of Tables:

Table 1. Snapshot of Global AI in Drug Discovery Market, 2019-2026 21
Table 2. Main Product Trends and Market Opportunities in Global AI in Drug Discovery Market 31
Table 3. Global AI in Drug Discovery Market by Offering, 2015-2026, $ mn 39
Table 4. Global AI in Drug Discovery Market by Technology, 2015-2026, $ mn 43
Table 5. Global AI in Drug Discovery Market by Drug Type, 2015-2026, $ mn 50
Table 6. Global AI in Drug Discovery Market by Therapeutic Area, 2015-2026, $ mn 54
Table 7. Selected Drug Development Pipelines Aided by AI 56
Table 8. Global AI in Drug Discovery Market by Application, 2015-2026, $ mn 62
Table 9. Global AI in Drug Discovery Market by End User, 2015-2026, $ mn 69
Table 10. Global AI in Drug Discovery Market by Region, 2015-2026, $ mn 75
Table 11. Leading National AI in Drug Discovery Market, 2019 and 2026, $ mn 77
Table 12. North America AI in Drug Discovery Market by Country, 2015-2026, $ mn 80
Table 13. U.S. AI in Drug Discovery Market by Technology, 2015-2026, $ mn 84
Table 14. U.S. AI in Drug Discovery Market by Therapeutic Area, 2015-2026, $ mn 84
Table 15. U.S. AI in Drug Discovery Market by End User, 2015-2026, $ mn 84
Table 16. Canada AI in Drug Discovery Market by Technology, 2015-2026, $ mn 87
Table 17. Canada AI in Drug Discovery Market by Therapeutic Area, 2015-2026, $ mn 87
Table 18. Canada AI in Drug Discovery Market by End User, 2015-2026, $ mn 87
Table 19. Mexico AI in Drug Discovery Market by Technology, 2015-2026, $ mn 89
Table 20. Mexico AI in Drug Discovery Market by Therapeutic Area, 2015-2026, $ mn 89
Table 21. Mexico AI in Drug Discovery Market by End User, 2015-2026, $ mn 89
Table 22. Europe AI in Drug Discovery Market by Country, 2015-2026, $ mn 92
Table 23. UK AI in Drug Discovery Market by Technology, 2015-2026, $ mn 95
Table 24. UK AI in Drug Discovery Market by Therapeutic Area, 2015-2026, $ mn 95
Table 25. UK AI in Drug Discovery Market by End User, 2015-2026, $ mn 95
Table 26. France AI in Drug Discovery Market by Technology, 2015-2026, $ mn 97
Table 27. France AI in Drug Discovery Market by Therapeutic Area, 2015-2026, $ mn 97
Table 28. France AI in Drug Discovery Market by End User, 2015-2026, $ mn 97
Table 29. Germany AI in Drug Discovery Market by Technology, 2015-2026, $ mn 99
Table 30. Germany AI in Drug Discovery Market by Therapeutic Area, 2015-2026, $ mn 99
Table 31. Germany AI in Drug Discovery Market by End User, 2015-2026, $ mn 99
Table 32. Spain AI in Drug Discovery Market by Technology, 2015-2026, $ mn 101
Table 33. Spain AI in Drug Discovery Market by Therapeutic Area, 2015-2026, $ mn 101
Table 34. Spain AI in Drug Discovery Market by End User, 2015-2026, $ mn 101
Table 35. Italy AI in Drug Discovery Market by Technology, 2015-2026, $ mn 103
Table 36. Italy AI in Drug Discovery Market by Therapeutic Area, 2015-2026, $ mn 103
Table 37. Italy AI in Drug Discovery Market by End User, 2015-2026, $ mn 103
Table 38. Russia AI in Drug Discovery Market by Technology, 2015-2026, $ mn 105
Table 39. Russia AI in Drug Discovery Market by Therapeutic Area, 2015-2026, $ mn 105
Table 40. Russia AI in Drug Discovery Market by End User, 2015-2026, $ mn 105
Table 41. AI in Drug Discovery Market in Rest of Europe by Country, 2015-2026, $ mn 107
Table 42. APAC AI in Drug Discovery Market by Country, 2015-2026, $ mn 110
Table 43. China AI in Drug Discovery Market by Technology, 2015-2026, $ mn 112
Table 44. China AI in Drug Discovery Market by Therapeutic Area, 2015-2026, $ mn 112
Table 45. China AI in Drug Discovery Market by End User, 2015-2026, $ mn 112
Table 46. Japan AI in Drug Discovery Market by Technology, 2015-2026, $ mn 115
Table 47. Japan AI in Drug Discovery Market by Therapeutic Area, 2015-2026, $ mn 115
Table 48. Japan AI in Drug Discovery Market by End User, 2015-2026, $ mn 115
Table 49. India AI in Drug Discovery Market by Technology, 2015-2026, $ mn 117
Table 50. India AI in Drug Discovery Market by Therapeutic Area, 2015-2026, $ mn 117
Table 51. India AI in Drug Discovery Market by End User, 2015-2026, $ mn 117
Table 52. Australia AI in Drug Discovery Market by Technology, 2015-2026, $ mn 119
Table 53. Australia AI in Drug Discovery Market by Therapeutic Area, 2015-2026, $ mn 119
Table 54. Australia AI in Drug Discovery Market by End User, 2015-2026, $ mn 119
Table 55. South Korea AI in Drug Discovery Market by Technology, 2015-2026, $ mn 121
Table 56. South Korea AI in Drug Discovery Market by Therapeutic Area, 2015-2026, $ mn 121
Table 57. South Korea AI in Drug Discovery Market by End User, 2015-2026, $ mn 121
Table 58. AI in Drug Discovery Market in Rest of APAC by Country, 2015-2026, $ mn 123
Table 59. South America AI in Drug Discovery Market by Country, 2015-2026, $ mn 126
Table 60. Argentina AI in Drug Discovery Market by Technology, 2015-2026, $ mn 128
Table 61. Argentina AI in Drug Discovery Market by Therapeutic Area, 2015-2026, $ mn 128
Table 62. Argentina AI in Drug Discovery Market by End User, 2015-2026, $ mn 128
Table 63. Brazil AI in Drug Discovery Market by Technology, 2015-2026, $ mn 130
Table 64. Brazil AI in Drug Discovery Market by Therapeutic Area, 2015-2026, $ mn 130
Table 65. Brazil AI in Drug Discovery Market by End User, 2015-2026, $ mn 130
Table 66. Chile AI in Drug Discovery Market by Technology, 2015-2026, $ mn 132
Table 67. Chile AI in Drug Discovery Market by Therapeutic Area, 2015-2026, $ mn 132
Table 68. Chile AI in Drug Discovery Market by End User, 2015-2026, $ mn 132
Table 69. RoW AI in Drug Discovery Market by Country, 2015-2026, $ mn 136
Table 70. UAE AI in Drug Discovery Market by Technology, 2015-2026, $ mn 138
Table 71. UAE AI in Drug Discovery Market by Therapeutic Area, 2015-2026, $ mn 138
Table 72. UAE AI in Drug Discovery Market by End User, 2015-2026, $ mn 138
Table 73. Saudi Arabia AI in Drug Discovery Market by Technology, 2015-2026, $ mn 140
Table 74. Saudi Arabia AI in Drug Discovery Market by Therapeutic Area, 2015-2026, $ mn 140
Table 75. Saudi Arabia AI in Drug Discovery Market by End User, 2015-2026, $ mn 140
Table 76. Egypt AI in Drug Discovery Market by Technology, 2015-2026, $ mn 142
Table 77. Egypt AI in Drug Discovery Market by Therapeutic Area, 2015-2026, $ mn 142
Table 78. Egypt AI in Drug Discovery Market by End User, 2015-2026, $ mn 142
Table 79. Use Cases of AI for Drug Discovery by Selected Pharmaceutical Companies 147
Table 80. Atomwise, Inc.: Company Snapshot 150
Table 81. Atomwise, Inc.: Business Segmentation 150
Table 82. Atomwise, Inc.: Product Portfolio 151
Table 83. Atomwise, Inc.: Revenue, 2016-2018, $ mn 151
Table 84. Atomwise, Inc.: Recent Developments 151
Table 85. Risk Evaluation for Investing in Global Market, 2019-2026 173
Table 86. Critical Success Factors and Key Takeaways 176

 

 

List of Figures:

Figure 1. Research Method Flow Chart 14
Figure 2. Breakdown of Primary Research 16
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation 18
Figure 4. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2026 20
Figure 5. Global AI in Drug Discovery Market, 2019-2026, $ mn 23
Figure 6. Primary Drivers and Impact Factors of Global AI in Drug Discovery Market 25
Figure 7. Primary Restraints and Impact Factors of Global AI in Drug Discovery Market 28
Figure 8. Investment Opportunity Analysis 32
Figure 9. Porter’s Fiver Forces Analysis of Global AI in Drug Discovery Market 35
Figure 10. Breakdown of Global AI in Drug Discovery Market by Offering, 2019-2026, % of Revenue 39
Figure 11. Contribution to Global 2020-2026 Cumulative Revenue by Offering, Value ($ mn) and Share (%) 40
Figure 12. Global AI in Drug Discovery Market: Software, 2015-2026, $ mn 41
Figure 13. Global AI in Drug Discovery Market: Service, 2015-2026, $ mn 42
Figure 14. Breakdown of Global AI in Drug Discovery Market by Technology, 2019-2026, % of Revenue 43
Figure 15. Contribution to Global 2020-2026 Cumulative Revenue by Technology, Value ($ mn) and Share (%) 44
Figure 16. Global AI in Drug Discovery Market: Deep Learning, 2015-2026, $ mn 45
Figure 17. Global AI in Drug Discovery Market: Supervised Learning, 2015-2026, $ mn 46
Figure 18. Global AI in Drug Discovery Market: Reinforcement Learning, 2015-2026, $ mn 47
Figure 19. Global AI in Drug Discovery Market: Unsupervised Learning, 2015-2026, $ mn 48
Figure 20. Global AI in Drug Discovery Market: Other Technologies, 2015-2026, $ mn 49
Figure 21. Breakdown of Global AI in Drug Discovery Market by Drug Type, 2019-2026, % of Revenue 50
Figure 22. Contribution to Global 2020-2026 Cumulative Revenue by Drug Type, Value ($ mn) and Share (%) 51
Figure 23. Global AI in Drug Discovery Market: Large-molecule Drugs, 2015-2026, $ mn 52
Figure 24. Global AI in Drug Discovery Market: Small-molecular Drugs, 2015-2026, $ mn 53
Figure 25. Breakdown of Global AI in Drug Discovery Market by Therapeutic Area, 2019-2026, % of Revenue 54
Figure 26. Contribution to Global 2020-2026 Cumulative Revenue by Therapeutic Area, Value ($ mn) and Share (%) 55
Figure 27. Global AI in Drug Discovery Market: Oncology, 2015-2026, $ mn 57
Figure 28. Global AI in Drug Discovery Market: Neurodegenerative Diseases, 2015-2026, $ mn 58
Figure 29. Global AI in Drug Discovery Market: Cardiovascular Disease, 2015-2026, $ mn 59
Figure 30. Global AI in Drug Discovery Market: Metabolic Diseases, 2015-2026, $ mn 60
Figure 31. Global AI in Drug Discovery Market: Other Therapeutic Areas, 2015-2026, $ mn 61
Figure 32. Breakdown of Global AI in Drug Discovery Market by Application, 2019-2026, % of Revenue 62
Figure 33. Contribution to Global 2020-2026 Cumulative Revenue by Application, Value ($ mn) and Share (%) 63
Figure 34. Global AI in Drug Discovery Market: Information & Data Analysis, 2015-2026, $ mn 64
Figure 35. Global AI in Drug Discovery Market: Drug Design, 2015-2026, $ mn 65
Figure 36. Global AI in Drug Discovery Market: Drug Evaluation, 2015-2026, $ mn 66
Figure 37. Global AI in Drug Discovery Market: Clinical Trials, 2015-2026, $ mn 67
Figure 38. Global AI in Drug Discovery Market: Other Applications, 2015-2026, $ mn 68
Figure 39. Breakdown of Global AI in Drug Discovery Market by End User, 2019-2026, % of Revenue 69
Figure 40. Contribution to Global 2020-2026 Cumulative Revenue by End User, Value ($ mn) and Share (%) 70
Figure 41. Global AI in Drug Discovery Market: Pharmaceutical & Biotechnology Companies, 2015-2026, $ mn 71
Figure 42. Global AI in Drug Discovery Market: Academic & Research Institutes, 2015-2026, $ mn 72
Figure 43. Global AI in Drug Discovery Market: Contract Research Organizations, 2015-2026, $ mn 73
Figure 44. Global Market Snapshot by Region 74
Figure 45. Geographic Spread of Worldwide AI in Drug Discovery Market, 2019-2026, % of Revenue 75
Figure 46. Contribution to Global 2020-2026 Cumulative Revenue by Region, Value ($ mn) and Share (%) 76
Figure 47. North American AI in Drug Discovery Market, 2015-2026, $ mn 79
Figure 48. Breakdown of North America AI in Drug Discovery Market by Country, 2019 and 2026, % of Revenue 79
Figure 49. Contribution to North America 2020-2026 Cumulative Revenue by Country, Value ($ mn) and Share (%) 80
Figure 50. U.S. AI in Drug Discovery Market, 2015-2026, $ mn 83
Figure 51. Canada AI in Drug Discovery Market, 2015-2026, $ mn 86
Figure 52. AI in Drug Discovery Market in Mexico, 2015-2026, $ mn 88
Figure 53. European AI in Drug Discovery Market, 2015-2026, $ mn 91
Figure 54. Breakdown of European AI in Drug Discovery Market by Country, 2019 and 2026, % of Revenue 91
Figure 55. Contribution to Europe 2020-2026 Cumulative Revenue by Country, Value ($ mn) and Share (%) 92
Figure 56. AI in Drug Discovery Market in UK, 2015-2026, $ mn 94
Figure 57. AI in Drug Discovery Market in France, 2015-2026, $ mn 96
Figure 58. AI in Drug Discovery Market in Germany, 2015-2026, $ mn 98
Figure 59. AI in Drug Discovery Market in Spain, 2015-2026, $ mn 100
Figure 60. AI in Drug Discovery Market in Italy, 2015-2026, $ mn 102
Figure 61. AI in Drug Discovery Market in Russia, 2015-2026, $ mn 104
Figure 62. AI in Drug Discovery Market in Rest of Europe, 2015-2026, $ mn 106
Figure 63. Asia-Pacific AI in Drug Discovery Market, 2015-2026, $ mn 109
Figure 64. Breakdown of APAC AI in Drug Discovery Market by Country, 2019 and 2026, % of Revenue 109
Figure 65. Contribution to APAC 2020-2026 Cumulative Revenue by Country, Value ($ mn) and Share (%) 110
Figure 66. AI in Drug Discovery Market in China, 2015-2026, $ mn 111
Figure 67. AI in Drug Discovery Market in Japan, 2015-2026, $ mn 114
Figure 68. AI in Drug Discovery Market in India, 2015-2026, $ mn 116
Figure 69. AI in Drug Discovery Market in Australia, 2015-2026, $ mn 118
Figure 70. AI in Drug Discovery Market in South Korea, 2015-2026, $ mn 120
Figure 71. AI in Drug Discovery Market in Rest of APAC, 2015-2026, $ mn 122
Figure 72. South America AI in Drug Discovery Market, 2015-2026, $ mn 125
Figure 73. Breakdown of South America AI in Drug Discovery Market by Country, 2019 and 2026, % of Revenue 125
Figure 74. Contribution to South America 2020-2026 Cumulative Revenue by Country, Value ($ mn) and Share (%) 126
Figure 75. AI in Drug Discovery Market in Argentina, 2015-2026, $ mn 127
Figure 76. AI in Drug Discovery Market in Brazil, 2015-2026, $ mn 129
Figure 77. AI in Drug Discovery Market in Chile, 2015-2026, $ mn 131
Figure 78. AI in Drug Discovery Market in Rest of South America, 2015-2026, $ mn 133
Figure 79. AI in Drug Discovery Market in Rest of the World (RoW), 2015-2026, $ mn 135
Figure 80. Breakdown of RoW AI in Drug Discovery Market by Country, 2019 and 2026, % of Revenue 135
Figure 81. Contribution to RoW 2020-2026 Cumulative Revenue by Country, Value ($ mn) and Share (%) 136
Figure 82. AI in Drug Discovery Market in UAE, 2015-2026, $ mn 137
Figure 83. AI in Drug Discovery Market in Saudi Arabia, 2015-2026, $ mn 139
Figure 84. AI in Drug Discovery Market in Egypt, 2015-2026, $ mn 141
Figure 85. Growth Stage of Global AI in Drug Discovery Industry over the Forecast Period 144
Figure 86. Share of Developments of Key Vendors by Strategy Type, 2015-2019 146

 

Reviews

There are yet no reviews for this product.